Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS-OIG
CVS’ Caremark and EndoGastric Solutions Enter into Corporate Integrity…
The Office of Inspector General (OIG) for the U.S. Department of Health & Human Services has been busy in 2014. By our count,…
HHS OIG 2014 Work Plan
The U.S. Department of Health & Human Services ("HHS") Office of Inspector General ("OIG") released its annual 2014 Work Plan.…
Endo Health Solutions Lidoderm Settlement and Corporate Integrity…
Endo Health Solutions, Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $171.9 million to resolve civil…
HHS-OIG Five Year Strategic Plan
Recently the U.S. Department of Health & Human Services Office of Inspector General issued a report on its "key focus areas"…
CareFusion Settlement Features Corporate Regulatory Officer as Whistle…
The U.S. Department of Justice (DOJ) recently announced a $40.1 million final settlement agreement with CareFusion Corp. to…
HHS-OIG: Listing of Pharmaceutical and Device Corporate Integrity…
In addition to analysis of major settlements and corporate integrity agreements, each year we update the listing of important…
False Claims Act Cases Could Signal Increased Whistleblower Litigation
A recent slew of Federal Claims Act (FCA) complaints may be the norm as whistleblowers are bringing more and more cases against…
FDA Clearance of Medical Devices Through 510K (FDA and HHS-OIG Reports)
The U.S. Department of Health and Human Services, Office of Inspector General issued a report: "FDA's Clearance of Medical Devices…
Johnson and Johnson Corporate Integrity Agreement: The Progression of Life…
Compliance managers at pharmaceutical companies and medical device manufacturers can stay ahead of enforcement trends by…
HHS OIG Reports CMS Not Catching All Overpayments
As reported by FierceHealth, a recent report by the Office of Inspector General claimed the Centers for Medicare &…